Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)
Completed
- Conditions
- Age Related Macular Degeneration
- Registration Number
- NCT00603850
- Lead Sponsor
- Notal Vision Ltd.
- Brief Summary
Demonstrate the ability of the current interactive tutorial and 1-800 support to teach an AMD patient to use the HMP device.
- Detailed Description
The pilot study purpose is to demonstrate that the tutorial which is a part of the device software, is giving sufficient training for the intended users.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
- Capable and willing to sign a consent form and participate in the study
- Subjects diagnosed as intermediate AMD in at least one eye
- Age >50 years
- VA with habitual correction >20/60 in the study eye
- Ability to speak, read and understand instructions in Hebrew
- Familiar with computer usage
Exclusion Criteria
- Evidence of macular disease other than AMD or glaucoma in the study eye
- Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, CFP.
- Any non-macular related ocular surgery performed within 3 months prior to study entry in the target eye
- Participation in another study with the exclusion of AREDS study
- Patients diagnosed with geographic atrophy (GA)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of subjects who manage to use the device as in a daily testing 1 month
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers correlate with HMP device usage outcomes in intermediate AMD patients?
How does the ForeseeHome tutorial compare to in-person training for home perimetry adherence in AMD?
Are there adverse events associated with home-based perimetry devices like the HMP in AMD management?
What molecular pathways in AMD progression might the HMP device's data inform for therapeutic development?
How does the HMP device's effectiveness in early detection compare to standard-of-care ophthalmic monitoring for intermediate AMD?
Trial Locations
- Locations (1)
Charlotte Eye Ear Nose & Throat
🇺🇸Charlotte, North Carolina, United States
Charlotte Eye Ear Nose & Throat🇺🇸Charlotte, North Carolina, United States